scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1007/S00296-008-0581-0 |
P698 | PubMed publication ID | 18398616 |
P50 | author | Brad H Rovin | Q114447183 |
P2093 | author name string | Tibor Nadasdy | |
Dan N Spetie | |||
Anjali Satoskar | |||
Hashim Mehter | |||
Lee Hebert | |||
Ruo-Qi Hu | |||
P2860 | cites work | Wegener's granulomatosis: current and upcoming therapies | Q24804964 |
Cyclophosphamide and hemorrhagic cystitis. | Q33467070 | ||
The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review | Q34381902 | ||
Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis | Q35600163 | ||
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients | Q39707375 | ||
Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients | Q40535853 | ||
Cyclophosphamide-induced bladder toxicity in wegener's granulomatosis | Q42213684 | ||
Severe cystitis induced by cyclophosphamide. Role of surgical management | Q42235001 | ||
Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy | Q43837378 | ||
Hyperbaric oxygen for cyclophosphamide-induced cystitis | Q44198091 | ||
Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab | Q46504507 | ||
Cyclophosphamide and severe hemorrhagic cystitis. | Q54733417 | ||
Urological Complications of Cyclophosphamide | Q69650804 | ||
Therapy in cytoxan hemorrhagic cystitis | Q71441984 | ||
Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation | Q73197278 | ||
Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients | Q73383313 | ||
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno | Q73567637 | ||
Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement | Q78223205 | ||
P433 | issue | 11 | |
P921 | main subject | literature review | Q2412849 |
case report | Q2782326 | ||
hemorrhagic cystitis | Q5712565 | ||
P304 | page(s) | 1161-1164 | |
P577 | publication date | 2008-04-09 | |
P1433 | published in | Rheumatology International | Q15763689 |
P1476 | title | Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review | |
P478 | volume | 28 |
Q38230018 | Bladder Cancer versus Hemorrhagic Cystitis: A Case of Mistaken Identity in a 34-Year-Old Male Undergoing Therapy for Granulomatosis with Polyangiitis |
Q37396014 | Cyclophosphamide Induces an Early Wave of Acrolein-Independent Apoptosis in the Urothelium |
Q46230305 | Ebselen attenuates cyclophosphamide-induced oxidative stress and DNA damage in mice |
Q37330013 | Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis |
Q33816592 | Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation |
Q35173027 | Inflammation and pyroptosis mediate muscle expansion in an interleukin-1β (IL-1β)-dependent manner |
Q46775302 | Simvastatin suppresses cyclophosphamide-induced changes in urodynamics and bladder inflammation |